Inactivated hepatitis A vaccine booster given =<24 months after the primary dose

By Landry P.   Tremblay S.   Darioli R.   Genton B.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 399-402

Elsevier

Access to resources Recommend Favorite

Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children

By Scheifele D.W.   Meekison W.   Guasparini R.   Roberts A.   Barreto L.   Thipphawong J.   Wiltsey S.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 104-108

Elsevier

Access to resources Recommend Favorite

A randomised comparison of two inactivated hepatitis A vaccines, Avaxim&unknown; and Vaqta&unknown;, given as a booster to subjects primed with Avaxim&unknown;

By Clarke P.   Kitchin N.   Souverbie F.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4429-4433

Elsevier

Access to resources Recommend Favorite

Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell&unknown; 2 vaccine

By Harbour D.A.   Gunn-Moore D.A.   Gruffydd-Jones T.J.   Caney S.M.A.   Bradshaw J.   Jarrett O.   Wiseman A.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2866-2872

Elsevier

Access to resources Recommend Favorite

Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age

By King J.C.   Vink P.E.   Ih C.   Kimura A.   Parks M.   Smilie M.   Lichenstein R.   Farley J.J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 361-365

Elsevier

Access to resources Recommend Favorite